Incidental Mutation 'R1451:Gars1'
ID 161657
Institutional Source Beutler Lab
Gene Symbol Gars1
Ensembl Gene ENSMUSG00000029777
Gene Name glycyl-tRNA synthetase 1
Synonyms Gena201, Sgrp23, Gars, GENA202
MMRRC Submission 039506-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R1451 (G1)
Quality Score 185
Status Validated
Chromosome 6
Chromosomal Location 55014992-55056485 bp(+) (GRCm39)
Type of Mutation splice site
DNA Base Change (assembly) T to C at 55030108 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000003572 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000003572]
AlphaFold Q9CZD3
Predicted Effect probably benign
Transcript: ENSMUST00000003572
SMART Domains Protein: ENSMUSP00000003572
Gene: ENSMUSG00000029777

DomainStartEndE-ValueType
low complexity region 4 27 N/A INTRINSIC
low complexity region 31 46 N/A INTRINSIC
WHEP-TRS 57 112 1.58e-8 SMART
Pfam:tRNA-synt_2b 281 582 2.1e-10 PFAM
Pfam:HGTP_anticodon 605 699 7.7e-24 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000203334
Predicted Effect noncoding transcript
Transcript: ENSMUST00000205258
Meta Mutation Damage Score 0.0898 question?
Coding Region Coverage
  • 1x: 98.8%
  • 3x: 97.8%
  • 10x: 94.4%
  • 20x: 86.3%
Validation Efficiency 96% (55/57)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PHENOTYPE: A dominant mutation results in sensory and motor axon degeneration in affected mice, with defects in synaptic transmission, nerve conduction and premature death. A loss of function mutation results in embryonic lethality in homozygous mice, and no discernable phenotype in heterozygous mice. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 54 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
1700024G13Rik T C 14: 32,098,588 (GRCm39) E83G possibly damaging Het
Abca9 A G 11: 110,018,273 (GRCm39) S1116P probably damaging Het
Abcc12 T A 8: 87,284,322 (GRCm39) T296S probably damaging Het
Adarb2 A G 13: 8,389,657 (GRCm39) probably benign Het
Arhgef12 C T 9: 42,903,874 (GRCm39) probably benign Het
Asah1 A G 8: 41,807,049 (GRCm39) probably null Het
C1ra A T 6: 124,498,600 (GRCm39) Q431L probably benign Het
C1s2 A T 6: 124,602,453 (GRCm39) I580N probably benign Het
Cacna2d4 C T 6: 119,213,785 (GRCm39) T68I probably benign Het
Car8 A T 4: 8,189,327 (GRCm39) H162Q probably benign Het
Ccdc106 A G 7: 5,062,527 (GRCm39) R116G probably damaging Het
Ccdc136 T A 6: 29,419,376 (GRCm39) N965K probably benign Het
Cd200r3 A G 16: 44,771,910 (GRCm39) E58G possibly damaging Het
Cnksr3 T A 10: 7,076,830 (GRCm39) S121C probably null Het
Cog6 T C 3: 52,916,534 (GRCm39) M212V possibly damaging Het
Ebna1bp2 C A 4: 118,478,269 (GRCm39) probably null Het
Epha1 C A 6: 42,338,385 (GRCm39) M730I probably damaging Het
Fcgbpl1 T C 7: 27,836,582 (GRCm39) F167S probably damaging Het
Fscn2 A T 11: 120,252,848 (GRCm39) E105V probably damaging Het
Itgb4 G T 11: 115,881,710 (GRCm39) G753V probably damaging Het
Kif23 C T 9: 61,832,084 (GRCm39) V634M probably damaging Het
Krt8 T C 15: 101,907,264 (GRCm39) Y273C possibly damaging Het
Lgmn A G 12: 102,372,151 (GRCm39) probably benign Het
Lrig3 T C 10: 125,845,926 (GRCm39) I785T possibly damaging Het
Lrriq1 A G 10: 103,038,376 (GRCm39) probably benign Het
Lta4h A G 10: 93,316,590 (GRCm39) D491G probably damaging Het
Megf10 A T 18: 57,385,931 (GRCm39) S315C probably damaging Het
Mphosph8 C T 14: 56,905,878 (GRCm39) R24C possibly damaging Het
Neurog2 A G 3: 127,427,490 (GRCm39) D38G possibly damaging Het
Or1j11 G T 2: 36,311,877 (GRCm39) A156S probably benign Het
Or2w2 A T 13: 21,758,457 (GRCm39) Y56* probably null Het
Or2z2 C T 11: 58,346,358 (GRCm39) R139H probably benign Het
Or6b3 T A 1: 92,439,517 (GRCm39) I78F possibly damaging Het
Or8b50 A T 9: 38,518,234 (GRCm39) I158F probably benign Het
Or8g50 T A 9: 39,648,612 (GRCm39) V167D probably benign Het
Pcdhb17 A T 18: 37,619,989 (GRCm39) D593V probably damaging Het
Pde2a G T 7: 101,071,198 (GRCm39) E23* probably null Het
Prex2 G A 1: 11,226,483 (GRCm39) V749I probably benign Het
Ptchd4 A G 17: 42,813,809 (GRCm39) Y570C probably damaging Het
Robo3 C T 9: 37,329,007 (GRCm39) R1237K probably benign Het
Slc6a1 C A 6: 114,284,756 (GRCm39) Y87* probably null Het
Snx13 G A 12: 35,128,983 (GRCm39) A34T probably benign Het
Sppl3 T C 5: 115,226,424 (GRCm39) L193P probably damaging Het
Tia1 A T 6: 86,407,321 (GRCm39) Y277F probably benign Het
Tns2 C T 15: 102,017,369 (GRCm39) R281C probably damaging Het
Trappc2l T C 8: 123,342,134 (GRCm39) F127L probably damaging Het
Ushbp1 G T 8: 71,838,663 (GRCm39) Q588K possibly damaging Het
Usp43 T A 11: 67,747,007 (GRCm39) H895L probably benign Het
Vmn1r179 T A 7: 23,628,275 (GRCm39) C155* probably null Het
Vmn2r8 T A 5: 108,945,933 (GRCm39) D558V probably damaging Het
Vps13a T C 19: 16,688,228 (GRCm39) T860A probably benign Het
Vps50 A G 6: 3,565,628 (GRCm39) N522S possibly damaging Het
Zfp180 T C 7: 23,804,643 (GRCm39) F354S probably benign Het
Zgpat A G 2: 181,021,984 (GRCm39) probably benign Het
Other mutations in Gars1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00818:Gars1 APN 6 55,027,338 (GRCm39) missense probably damaging 1.00
IGL01084:Gars1 APN 6 55,032,812 (GRCm39) missense probably benign
IGL01514:Gars1 APN 6 55,042,505 (GRCm39) missense probably benign 0.01
IGL02104:Gars1 APN 6 55,054,682 (GRCm39) missense probably damaging 1.00
IGL02349:Gars1 APN 6 55,025,049 (GRCm39) splice site probably benign
IGL02371:Gars1 APN 6 55,042,452 (GRCm39) missense probably benign 0.08
IGL02932:Gars1 APN 6 55,037,929 (GRCm39) missense probably damaging 1.00
BB006:Gars1 UTSW 6 55,040,102 (GRCm39) missense probably damaging 1.00
BB016:Gars1 UTSW 6 55,040,102 (GRCm39) missense probably damaging 1.00
IGL02799:Gars1 UTSW 6 55,040,084 (GRCm39) missense probably damaging 1.00
R0637:Gars1 UTSW 6 55,046,472 (GRCm39) critical splice donor site probably null
R0762:Gars1 UTSW 6 55,054,565 (GRCm39) splice site probably null
R1846:Gars1 UTSW 6 55,040,153 (GRCm39) missense probably benign 0.05
R1988:Gars1 UTSW 6 55,054,757 (GRCm39) missense probably null 0.00
R2033:Gars1 UTSW 6 55,054,708 (GRCm39) missense probably benign 0.02
R2566:Gars1 UTSW 6 55,042,548 (GRCm39) missense probably damaging 1.00
R4706:Gars1 UTSW 6 55,046,363 (GRCm39) missense probably damaging 0.99
R4854:Gars1 UTSW 6 55,023,403 (GRCm39) missense probably damaging 0.99
R5055:Gars1 UTSW 6 55,045,077 (GRCm39) missense probably damaging 1.00
R5558:Gars1 UTSW 6 55,042,592 (GRCm39) missense probably damaging 1.00
R6306:Gars1 UTSW 6 55,032,809 (GRCm39) missense probably damaging 1.00
R6821:Gars1 UTSW 6 55,056,323 (GRCm39) missense probably benign 0.00
R7376:Gars1 UTSW 6 55,050,344 (GRCm39) missense probably benign 0.00
R7505:Gars1 UTSW 6 55,029,162 (GRCm39) missense probably benign 0.00
R7579:Gars1 UTSW 6 55,054,688 (GRCm39) missense probably damaging 1.00
R7605:Gars1 UTSW 6 55,054,735 (GRCm39) missense probably damaging 1.00
R7728:Gars1 UTSW 6 55,027,371 (GRCm39) missense probably damaging 1.00
R7929:Gars1 UTSW 6 55,040,102 (GRCm39) missense probably damaging 1.00
R8014:Gars1 UTSW 6 55,050,392 (GRCm39) missense probably benign
R8391:Gars1 UTSW 6 55,025,127 (GRCm39) missense probably damaging 1.00
R8418:Gars1 UTSW 6 55,042,446 (GRCm39) missense probably damaging 0.99
R8704:Gars1 UTSW 6 55,040,215 (GRCm39) missense probably damaging 0.98
R9350:Gars1 UTSW 6 55,029,249 (GRCm39) missense probably null 0.57
Predicted Primers PCR Primer
(F):5'- TCCCTGCGAAAGTGTCAGTGAAC -3'
(R):5'- TGCATTTTGCTCAGGCAGAACTCC -3'

Sequencing Primer
(F):5'- agcactggctgctctttc -3'
(R):5'- CAGAACTCCAGACAGGCGTG -3'
Posted On 2014-03-14